Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of PAUL Glaucoma Implant® for Refractory Uveitic Glaucoma.

Ocular immunology and inflammation·2026
Same author

Performance of the ISOLD Score (Interleukin Score for IntraOcular Lymphoma Diagnosis) in the Diagnosis of Vitreoretinal Lymphoma in Clinical Practice.

American journal of ophthalmology·2026
Same author

Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease.

PLoS neglected tropical diseases·2026
Same author

Treatment Approaches for Posterior Uveitis in Ocular Sarcoidosis: A Narrative Review.

Seminars in ophthalmology·2026
Same author

Bilateral Giant Pigment Epithelial Detachments and Unilateral RPE Tear and Exudative Retinal Detachment After Tadalafil Exposure: Case Report and Review of the Literature.

Retinal cases & brief reports·2026
Same author

Tofacitinib: New drug in the therapeutic armamentarium in ocular inflammation.

Indian journal of ophthalmology·2026

Related Experiment Video

Updated: Dec 11, 2025

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.0K

Drug-induced uveitis: A review.

Manisha Agarwal1, Parthopratim Dutta Majumder2, Kalpana Babu3

  • 1Vitreoretina and Uveitis Services, Dr. Shroff's Charity Eye Hospital, New Delhi, India.

Indian Journal of Ophthalmology
|August 23, 2020
PubMed
Summary

Drug-induced uveitis (DIU) is a rare but significant cause of ocular inflammation. Awareness and identification of the causative drug are crucial for effective management and potential recovery.

Keywords:
Drug induced uveitisuveitis with intravitreal drugsuveitis with systemic drugsuveitis with topicalsuveitis with vaccines

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.8K
Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis
06:57

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis

Published on: March 8, 2018

9.2K

Related Experiment Videos

Last Updated: Dec 11, 2025

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.0K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.8K
Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis
06:57

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis

Published on: March 8, 2018

9.2K

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • Uveitis, or inflammation of the uvea, can arise from various causes.
  • Drug-induced uveitis (DIU) is an uncommon but important etiology of ocular inflammation.
  • Medications can be administered systemically, topically, or intravitreally, leading to DIU.

Purpose of the Study:

  • To provide an overview of drug-induced uveitis (DIU).
  • To raise awareness of DIU as a clinical entity.
  • To highlight the importance of identifying causative drugs for managing uveitis.

Main Methods:

  • Extensive literature review conducted using PubMed.
  • Analysis of existing research on drug-induced uveitis.

Main Results:

  • Drug-induced uveitis can manifest in various forms, including anterior, intermediate, posterior, and panuveitis.
  • Less commonly, DIU may present as episcleritis or scleritis.
  • Identifying the offending drug is key to treatment.

Conclusions:

  • Stopping the causative medication can lead to uveitis recovery.
  • Concomitant use of corticosteroids may aid in managing DIU.
  • Increased awareness of DIU is essential for ophthalmologists and clinicians.